In addition, when expanding the analysis of pathologic lymph node activity to other cancers, N+ patients exhibit significantly higher EDA-FN and EDB-FN expression than N0 patients on average, suggesting the potential for oncofetal FNs as unique molecular targets for aiding in the predictive diagnosis of lymph node activity (Supplementary Figure S3). The gene discussed is FN1; the disease is cancer.